C

Cour Pharmaceuticals Development Company, Inc.

45 employees

Cour Pharmaceuticals Development is developing nanoparticle technology to help reset the immune system of multiple sclerosis (MS) patients.

Basic info

Industry

pharmaceutical manufacturing

Sectors

Biotechnology
Immunology
Therapeutics
Immune Tolerance
Inflammation
Pharmaceutical
Nanomedicine
Nanotechnology
Pharmaceuticals

Date founded

2015

FAQ